about
Biochemical and pharmacological characterization of three opioid-nociceptin hybrid peptide ligands reveals substantially differing modes of their actions.Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting.Novel unit B cryptophycin analogues as payloads for targeted therapy.In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell CarcinomasConjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug DeliverySynthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin ConjugatesSynthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery
P50
Q44349857-1EB37991-D77C-452B-AA22-3B62C095F65AQ48202119-65C1D01C-D533-4664-8C97-A717140F6495Q55415772-632B6926-58B1-40DF-A545-CF64F24CA874Q59807535-C667C099-DF13-44C6-A92F-304A71FE63B8Q91643705-1970EBCD-2BD0-4088-B70B-D30E9C578501Q92677533-8984CD88-2BCC-4CAB-A2B6-77186B507DBBQ92794475-B2811628-1F68-49C4-A46A-69BF7001DE8B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Adina Borbély
@ast
Adina Borbély
@en
Adina Borbély
@es
Adina Borbély
@nl
type
label
Adina Borbély
@ast
Adina Borbély
@en
Adina Borbély
@es
Adina Borbély
@nl
prefLabel
Adina Borbély
@ast
Adina Borbély
@en
Adina Borbély
@es
Adina Borbély
@nl
P106
P31
P496
0000-0002-5506-6555